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Abstract
Hypertension and associated disorders are major risk factors for cardiovascular disease. The Lyon
Hypertensive rat (LH) is a genetically hypertensive strain that exhibits spontaneous and salt-
sensitive hypertension, exaggerated proteinuria, high body weight, hyperlipidemia and elevated
insulin-to-glucose ratio. Previous genetic mapping identified Quantitative Trait Loci (QTL)
influencing blood pressure on chromosome 13 (RNO13) in several models of hypertension. To
study the effects of a single chromosome on the mapped traits, we generated consomic strains by
substituting LH RNO13 with that of the normotensive Brown Norway (BN) strain (LH-13BN) and
reciprocal consomics by substituting a BN RNO13 with that of LH (BN-13LH). These reciprocal
consomic strains, as well as the two parental strains were characterized for blood pressure,
metabolic and morphological parameters. Compared to LH parents, LH-13BN rats showed
decreased mean blood pressure (up to −24 mmHg on 2%NaCl in the drinking water), urine
proteins and lipids, and increased body weight. Differences between BN-13LH and BN rats are
much smaller than those observed between LH-13BN and LH rats, demonstrating the effects of the
highly resistant BN genome background. Plasma renin activity is not affected by the substitution
of RNO13, despite the significant blood pressure differences.
The present work demonstrates that RNO13 is a determinant of BP, proteinuria, and plasma lipids
in the LH rat. The distinct phenotypic differences between the consomic LH-13BN and the LH
make it a powerful model to determine genes and pathways leading to these risk factors for
cardiovascular and renal disease.
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INTRODUCTION
Hypertension is an important public health problem affecting about 65 million individuals in
the United States alone [1]. Essential hypertension is traditionally viewed as a consequence
of interactions between environmental and genetic factors (multifactorial). Despite
numerous attempts, the majority of these genetic determinants remain to be identified [2].
One way to avoid some of the complications associated with genetic research in humans
(heterogeneity of population, variability of environment), is to use animals models. Because
the coding regions of the rat genome sequence are on average > 85% identical to that of
man, there is a clear probability that the function of some genes identified in rats can be
translated directly to human or, failing this, can be used as “indicators” [3].
The Lyon Hypertensive (LH/Mav) rat strain [4], initially selected for spontaneous
hypertension, shares many features with the human metabolic syndrome
[5,6,7,8,9,10,11,12]. Indeed, this genetically hypertensive strain also suffers salt-sensitive
hypertension [13], altered renal functions with an exaggerated proteinuria [14], an excessive
body weight together with increased plasma lipids and insulin-to-glucose ratio [15].
To find the genetic causes of multifactorial diseases like hypertension and associated
disorders, our approach began with the identification of Quantitative Trait Loci (QTLs)
which are statistically linked to the blood pressure (BP) level or to any other related
phenotype. Since linkage analysis, in Dahl Salt Sensitive rats (SS) [16], Spontaneous
Hypertensive Rats (SHR) [17,18,19,20] as well as in LH rats [21,22] suggested that a
QTL(s) influencing blood pressure exist on rat chromosome 13 (RNO13), particularly in or
near the renin gene, we sought to study the role of RNO13 in the LH rat. Therefore, we
started the development of reciprocal consomic rat strains, i.e. animals which differ from the
parental strains by a whole chromosome (here RNO13) using marker assisted selection [23].
We choose as normotensive control strain, the Brown Norway (BN/NHsdMcwi) rat, which
is genetically divergent from the LH. LH-13BN is a LH rat in which RNO13 has been fully
substituted by a BN RNO13; conversely, BN-13LH is a BN rat with a RNO13 from LH rats.
Using a highly divergent strain was advantageous for two reasons: 1. it provided
polymorphic markers spanning the chromosome to ensure complete chromosome
substitution and 2. it allows us to uncover the maximum phenotypic differences due to
genetic variation, including those not captured by the previous cross between LH and LN,
strains with high genetic similarity. In order to determine the functional importance of
RNO13, male LH-13BN, BN-13LH as well as the parental LH and BN strains, were
characterized for not only blood pressure but also several additional phenotypes typical of
LH rats, as additional significant traits could be unmasked with the substitution of the BN
chromosome.
METHODS
Generation of consomic rats
The development of the consomic strains in this study involved the reciprocal transfer of the
RNO13, from BN (BN/NHsdMcwi) to the genetic background of LH (LH/Mav), and from
LH to the genetic background of BN. This required the production of an F1 generation by
crossing a male LH with a female BN. The male F1 hybrids obtained were then mated to the
desired recipient strain (LH or BN). After every backcross, DNA was extracted from tail tips
and genotyped with markers evenly distributed on RNO13 at a 5 cM resolution (D13Mgh13,
D13Rat39, D13Rat91, D13Mit 4, D13Mgh3, D13Rat 37, D13Rat85, D13Rat33, and
D13Rat88) and 146 markers spanning the remaining genome at a ~10cM resolution as
previously described [24]. Polymorphic markers were selected using the Genome Scanner
Tool available at the Rat Genome Database (RGD; http://www.rgd.mcw.edu). Male rats,
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heterozygous for the entire chromosome, were selected for the subsequent generation of
breeding. The backcrosses were followed until obtaining animals heterozygous for the full
length of RNO13 and homozygous LH or BN for the rest of the genome. These animals
were then intercrossed to fix the donor RNO13 as BN or LH and to obtain founders for the
reciprocal consomic strains. The reciprocal consomic lines (LH-13BN and BN-13LH) were
then maintained by brother-sister mating.
Animals
The animals (LH, LH-13BN, BN-13BN and BN) were housed in controlled conditions
(temperature 21±1°C, humidity 60±10%, lighting 8AM to 8PM), and received a standard rat
chow containing 0.3% sodium chloride (Elevage AO3, SAFE, Augy, France) and tap water
ad libitum. The protocols leading to these results followed our institutional guidelines which
have been approved by the veterinary services of the prefecture.
Protocol
This study is a component of a larger project to characterize consomic strains for several
chromosomes derived from LH and BN rats.
Because of technical considerations, the study of all the consomic strains, as well as the
parental strains, was performed simultaneously. Consequently, the parental strains were the
same as in our previous study [25] and the framework of the protocol is identical for all the
strains, as previously described, with the exception that some biochemical measurements
differ among the different consomic strains, as described below.
Briefly, 15 weeks old male rats were equipped with telemetric radio-transmitters
(TA11PAC40, Data Sciences International, St Paul, MN). After 3 weeks of recovery, BP
was recorded in baseline conditions, during various salt loads (1 or 2% NaCl as drinking
water) and after a washout period. 24-hours urine collections were also performed in
baseline conditions, at the end of the salt load and at the end of the washout period. At the
end of the study, 25 weeks-old animals fasted since 16h, were given a diazepam injection
(5mg/kg, ip) and euthanized by decapitation.
Urine collection, blood and tissues sampling
A blood sample was drawn on heparin at the time of the sacrifice in fasted rats to measure
creatinine, total cholesterol, triglycerides and glucose using Olympus automated tests (AU
2700 biochemistry analyzer, Olympus, Rungis, France), insulin (radioimmunoassay,
DiaSorin, Antony, France) and plasma renin activity (PRA). For PRA-measurement, plasma
contained additional ethylenediaminetetraacetate 20mM.
24-hours urines were used to measure creatinine, total proteins (pyrogallol red colorimetric
method: AU 2700 biochemistry analyzer, Olympus, Rungis, France), sodium and potassium
(flame photometer IL 943, Instrumentation Laboratory, Paris, France).
The left ventricle with septum was dissected out and weighed.
Measurement of plasma renin activity
Plasma renin activity was measured by trapping of generated angiotensin I by high affinity
antibodies and subsequent radioimmunoassay [26].
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Statistical analysis
Results are mean ± SEM. Statistical differences between strains were assessed using an
independent t-test. LH rats were compared to BN rats and the consomic (LH-13BN and
BN-13LH) were compared to their respective control (LH and BN rats).
Differences were considered statistically significant at p<0.05.
RESULTS
Body weight
Figure 1 shows, as previously described [25], that LH rats exhibit a much larger body weight
than BN rats. Interestingly, LH-13BN rats showed a significantly larger body weight than LH
rats, while body weight was lower in BN-13LH rats than in BN parents.
Cardiovascular parameters
Because differences in systolic, diastolic and mean BP (MBP) in the four strains are similar,
only MBP values are presented here (Figure 2). Under baseline conditions, MBP of LH rats
is approximately 40mmHg higher than that of BN rats (126 ± 0.9 mmHg vs 88 ± 1.6 mmHg,
p<0.01). LH-13BN rats exhibited a markedly lower baseline MPB than LH rats (113 ± 1.9
mmHg vs 126 ± 0.9 mmHg, p<0.01) while BN-13LH rats showed no difference in MBP
compared to BN rats (90 ± 1.6 mmHg vs 88 ± 1.6 mmHg). These MBP differences persisted
throughout the study.
As shown by Figure 3, 2% NaCl in the drinking water resulted in a more marked MBP
increase in LH rats than in BN. In LH-13BN, MBP was less affected by NaCl 2% than in LH
rats, although there was a 24 mmHg difference between LH and LH-13BN. BN-13LH did not
differ from BN rats.
The relative (mg/100g of body weight) left ventricle (LV) weight was higher in LH than in
BN rats (247 ± 1mg/100g vs 199 ± 4mg/100g, p<0.01). In LH-13BN, the relative LV weight
was decreased compared to LH rats (219 ± 3mg/100g vs 247 ± 1mg/100g, p<0.01) while, in
BN-13LH rats, there was a non-significant increase in relative LV weight compared to BN
rats (207 ± 3mg/100g vs 199 ± 4mg/100g).
Renal function and plasma renin activity (Table 1)
The glomerular filtration rate (GFR), approximated by creatinine clearance, did not
consistently differ among the four strains. However, urinary excretion of proteins was 6 to
11 fold greater in LH than in BN rats. BN-13LH exhibited the same proteinuria as the BN
while, in LH-13BN rats, urinary excretion of proteins was 50% lower than that of LH
parents.
Under baseline conditions, relative urinary excretion of Na+ did not consistently differ
among the four strains. However, at the end of the salt load, urinary excretion of Na+ was
significantly higher in LH than in BN rats. It was significantly lower in LH-13BN than in LH
while it was higher in BN-13LH than in BN parents.
As shown by Table 1, before and after salt load, the Na/K ratio was lower in LH and
LH-13BN than in BN and BN-13LH. At the end of the salt load, i.e. in 23 weeks old rats,
these differences were less marked and the BN-13LH exhibited the higher Na/K ratio.
LH rats showed a lower plasma renin activity than BN rats (Table 1). However, LH-13BN
and BN-13LH rats exhibited the same level of plasma renin activity as their parental controls.
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Metabolism (Table 2)
Plasma total cholesterol and triglycerides were higher in fasted LH than in BN rats. Plasma
total cholesterol was markedly decreased in LH-13BN rats compared to LH rats but remained
higher than in BN-13LH and BN rats. LH-13BN also showed decreased plasma triglycerides
compared to LH rats while BN-13LH exhibited the same level of triglycerides as BN rats.
In fasted conditions, the four strains exhibited similar glycemia; however, the insulin- to-
glucose ratio was significantly elevated in both LH and LH-13BN compared to BN and
BN-13LH. No significant differences were found between the consomics and their respective
parental strains.
DISCUSSION
We developed consomic rats, which differ from their parents by less than 5% of their
genome (RNO13), because this approach provides a well-controlled model to dissect the
genetic and physiological components of complex diseases such as BP and metabolic
abnormalities due to a locus or loci on a single chromosome. Using this approach in RNO13
reciprocal consomics allowed us to confirm the effects of LH chromosome 13 on blood
pressure regulation and also allowed us to identify novel effects of LH RNO13 on plasma
lipids, protein excretion, and body weight.
While the most likely choice for consomics might have been LH and its commonly used
normotensive control LN (Lyon Normotensive), the high genetic similarity between these
two strains, simultaneously selected from the same colony of outbred Sprague Dawley, and
the lack of markers available at the beginning of the project greatly reduced the ability to
ensure substitution of the entire chromosome. Therefore, in order to substitute RNO13 in its
entirety, we sought to use a donor strain that was more genetically diverse – BN. Our results
from introducing the BN RNO13, were not completely reflective of the results from the
previous linkage study involving the LH and LN rat strains. This could be due to the effects
of a mixed genome background in the LH × LN cross or due to the genome differences
between the LN and BN strains. Likely both scenarios are playing a role. However, the use
of the BN as a chromosome donor offered some distinct advantages for genetic dissection of
hypertension and phenotypes related to the metabolic syndrome in the LH rat. The LH and
LN strains share over 90% genetic identity, as evidenced by the genotyping of >20,000
SNPs spanning the genome [27], while LH and BN share less than 5% genome identity.
Therefore, the high genetic similarity between the LH and LN means many disease
susceptible alleles would remain unidentified as they are actually shared between the strains.
By introgressing the BN RNO13, we recapitulated the blood pressure phenotype on RNO13
that also mapped in the genetic cross between the LH and LN. Furthermore, we were able to
identify novel loci where LH confers susceptibility to dyslipidemia and related features of
the metabolic syndrome. In and of itself, the consomic strain has uncovered several
interesting phenotypes that have genetic effects initiated by chromosome substitution.
Indeed, this could have been our starting point, rather than first performing a large mapping
cross followed by consomic dissection. Because we have the ability to generate overlapping
congenics strains derived from the consomics, we now are able to dissect the phenotypes
and to identify those genes, which is a distinct advantage of mapping using consomics
compared to genetically unique F2 offspring that cannot be further studied after the initial
mapping. Moreover, the genome of the BN strain has been sequenced [28], extensively
characterized [29] and used as normotensive control strain for the development of consomic
strains in other model of hypertension [30,31].
The integration of a BN RNO13 in the LH genetic background induced significant
differences from the parental LH while the reciprocal consomic (the integration of a LH
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RNO13 in the BN background) did not always show a phenotypic difference. It is likely that
additional background susceptibility factors are required which are not found in BN rat, as
has been seen in other studies [32] or that the BN rat is genetically resistant to hypertension
and other characteristics of the metabolic syndrome. It is also likely the BN genome is
highly resistant to high blood pressure and that the introduction of a single susceptibility
factor from the LH is not sufficient to overcome homeostatic pressure keeping blood
pressure regulated. This is not a new concept by any means, even when generating
consomics and congenics from the same strains as used in mapping crosses. For example, in
one study we recently published [33], introgression of all three major BP QTL alleles from
the Genetically Hypertensive (GH) rat, independently or in a triple congenic, onto the
background of the BN rat was not sufficient to significantly raise blood pressure.
Conversely, consomics are very useful for identifying additional loci in the absence of
genome background effects. For example, in an F2 male cohort from a mapping cross
between the Dahl Salt Sensitive (SS) and the normotensive BN rats [34], a blood pressure
QTL was not determined on RNO13, yet the SS-13BN consomic shows a significant
decrease in blood pressure and is being studied extensively for additional cardiovascular
phenotypes [30,35,36,37]. Importantly, the goal of our work is to identify the factors that
alter the phenotypes in the LH rat. Therefore, the fact that replacing the LH RNO13 with
that of a highly resistant BN, resulted a clear and significant decrease in blood pressure,
allows us to generate congenic lines with clear phenotypic differences and increases our
likelihood of identifying the disease-causing alleles. Given we have the reciprocal
consomics available (BN-13LH), we could also pursue the mapping of BN modifier genes by
an F2 intercross between BN-13LH and LH.
Measures of plasma lipids showed LH rats have higher plasma concentrations of cholesterol
and triglycerides than BN rats, similar to that of LN controls [15]. The introduction of a BN
RNO13 in a LH genetic background reduced triglycerides and cholesterol, while the
introduction of an LH RNO13 in a BN background did not affect these parameters (again we
would hypothesize BN has strong compensatory mechanisms to regulate plasma lipids).
This suggests that RNO13 is involved in the spontaneous hyperlipidemia shown by LH rats.
The previous linkage study failed to reveal any QTL influencing plasma lipids on this
chromosome [22]; the introduction of a different donor strain or the differences in the
genome background can lead to the identification of new loci influencing a trait [23,38]. The
substitution of the LH RNO13 markedly reduced plasma triglycerides. Interestingly, in our
previous study [25], the replacement of LH RNO17 with that of the BN, also reduced
plasma triglycerides to the level observed in BN parents suggesting a strong independent
effect of RNO17 on hyperlipidemia or a common pathway with major components on both
chromosomes. Taken together, these results allow us to hypothesize that the
hypertriglyceridemia observed in LH rats is controlled by loci in at least two chromosomes
(RNO17 and RNO13). It remains to be seen if there is epistatic relationships between these
loci or if they fall within independent regulatory pathways. The generation of double
consomic (LH-17BN.13BN) will help address potential interactions.
Interestingly, LH-13BN rats have a significantly increased body weight compared to LH, and
BN-13LH a decreased body weight compared to BN. Such a result was unexpected. First, as
the LH rats are significantly heavier than BN, we would have expected the substitution of an
LH RNO13 with that of a BN would reduce body weight and, conversely, the substitution of
a BN chromosome with that of LH would result in higher body weight. Furthermore, our
genetic linkage studies between LH and LN rats [21,22] failed to reveal significant body
weight QTL on RNO13. Our results suggest that a gene(s) on LH RNO13 actually
contributes to reduced weight, but that genes on other chromosomes (e.g. RNO1 and
RNO17) play a stronger role and determine the overweight phenotype seen in the LH rat
[22,25]. In further studies, it will be important to investigate if the modification of body
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weight is the consequence of a change in height or in adiposity and to evaluate the
repartition of this adiposity. However, what is intriguing is that the consomic strains have
allowed us to clearly partition body weight from dyslipidemia as both reciprocal consomics
show marked opposite effects of chromosome substitution on body weight and plasma lipid
levels.
Under baseline diet conditions, mean blood pressure is decreased in LH-13BN compared to
LH rats. This difference is more marked than previously observed in LH-17BN consomic
rats [25]. Thus the substitution of RNO13 independently influences blood pressure in LH
rats. However, the converse is not true: the introduction of a LH RNO13 in a BN
background did not significantly increased BP. During salt load, BP remained stable in BN
while it increased gradually in BN-13LH, LH-13BN and LH rats. This demonstrates that
RNO13 is partially implicated in the salt sensitivity observed in LH rats. Similar data were
reported in Dahl salt sensitive rats in which the introduction of a BN RNO13 conferred
protection from salt induced hypertension [30]. Recently the generation of overlapping
congenics from these consomic rats demonstrated that the RNO13 contain 4 regions that
interact epistatically. Among these, two of them were sex specific [36].
Similarly, the urinary Na/K ratio, which is inversely related to mineralocorticoids activity,
was lower in LH and LH-13BN compared to BN and BN-13LH. This is in accordance with
the increase in mineralocorticoids found in LH rats [39]. However, the lack of significant
difference due to the substitution of RNO13 suggests it is independent of RNO13.
In LH-13BN, total urinary excretion of proteins is reduced compared to LH parents.
However, because the reduction in protein excretion could also be the consequence of the
decrease of the deleterious effects of hypertension on the kidneys, we can not definitively
conclude that this reduction is directly influenced by specific RNO13 genes. However,
generation of congenic substrains should enable us to examine independent and pleiotropic
gene effects.
Finally, this study allowed us to confirm that LH rats are a model of low renin hypertension
[40]. Because LH-13BN and BN-13LH rats exhibit the same level of plasma renin activity as
their controls (LH and BN rats, respectively) and LH and BN rats differ by a polymorphism
of the intron A of the renin gene [41], it is unlikely that the level of plasma renin activity is
related to this polymorphism, and may in fact be regulated by loci on another chromosome,
i.e. in trans. We can also conclude that, in our model, an important part of hypertension is
independent of plasma renin activity level.
Taken together these results allowed us to dissect characteristics of LH rats related to
hypertension and metabolic syndrome. It is interesting to observe that several parameters
such as BP, protein excretion and plasma lipids evolved similarly and independently of
plasma renin activity. Although this study does not allow us to entirely exclude renin as a
candidate gene for spontaneous hypertension in the LH rat, it demonstrates that, if the renin
gene is a determinant of essential hypertension in our model, this occurs independently of
plasma renin activity.
According to the current data in the Rat Genome Database, which is responsible for curating
all rat genes, there are 826 genes on rat RNO13.To identify other potential candidate gene,
we queried PubMed for genes on RNO13 annotated with the terms ‘hypertension OR blood
pressure OR lipids OR metabolic syndrome’. Thirteen genes in addition to Renin were
identified: Adora1 (adenosine A1 receptor); Ptgs2 (prostaglandin-endoperoxide synthase 2;
aka Cox2); RGD1307782 (similar to Williams-Beuren syndrome critical region protein 27);
Atp1a2 (ATPase, Na+/K+ transporting, alpha 2 polypeptide); Soat1 (sterol O-
acyltransferase 1); Avpr1b (arginine vasopressin receptor 1B); Hsd11b1 (hydroxysteroid 11-
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beta dehydrogenase 1); LOC679692 (similar to lysophosphatidylglycerol acyltransferase 1);
Selp (selectin, platelet); Myoc (myocilin); Rgs2 (regulator of G-protein signaling 2); Rgs5
(regulator of G-protein signaling 5); Prdx6 (peroxiredoxin 6). Until we have generated and
characterized congenic strains derived from the consomic strains, we cannot formally
include or exclude any of these, but they are candidates for follow-up in congenic and gene
expression studies.
In conclusion, this work shows that the consomic strains approach is a useful step in the
dissection of a highly complex disease like hypertension and components of the metabolic
syndrome. However, one of the limitations of this kind of study is that loci mapped as a
single QTL are more often composed of multiple QTLs with small and/or opposing effects
on the trait of interest. Therefore the observed phenotype in the consomic strain is the sum
of all allelic variation between the parental strains. Since we demonstrated here that RNO13
of LH rats has a significant influence on hypertension we can use these consomic animals to
develop overlapping congenic strains [42] for further dissection of the factors on RNO13.
The same strategy permitted Moreno et al. to identify four regions within RNO13
influencing blood pressure in SS rat with sexual dimorphisms [36]. By this approach, the
study of males and females in overlapping congenics derived from our consomic lines may
allow us to further understand the complex actions and interactions in regulating BP and
metabolic abnormalities shown by LH rats. Interestingly, there is a very close phylogenetic
relationship between the SS and the LH rats [27]. Given the fact that the same BN donor
strain (BN/NHsdMcwi) was used in this study as that of the SS-13BN strain [36], future
genotype-phenotype correlations could utilize these genetic similarities in assessing
candidate genes or modifier gene for common traits measured in each consomic or parental
lines.
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BP Blood Pressure
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Figure 1.
Time course evolution of body weight in LH (n=10), LH-13BN (n=10), BN-13LH (n=9) and
BN rats (n=10). ** p<0.01 LH versus BN; †† p<0.01 LH-13BN versus LH; ‡ p<0.05, ‡‡
p<0.01 BN-13LH versus BN.
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Figure 2.
Time course of mean blood pressure (MBP) recorded by radio telemetry in LH rats (n=10),
LH-13BN (n=10), BN-13LH (n=9) and BN rats (n=10). The telemetric radio-transmitters
were implanted at 15 weeks of age. The blood pressure recording periods were indicated by
the abbreviation RX (R1 for the first recording to R10). Each MBP value corresponds to the
average of a 22-h beat-to-beat MBP recording. The values of the first 2 recordings (R1, R2)
were averaged to obtain the baseline value (R1+2). The top of the graph shows the nature and
the chronology of the different salt load (1% and 2% NaCl in drinking water). ** p<0.01 LH
versus BN; †† p<0.01 LH-13BN versus LH; ‡ p<0.05 BN-13LH versus BN.
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Figure 3.
Percentage of mean blood pressure increase versus baseline value (R1+2) during high salt
load (2% NaCl as drinking water). R6 and R7 correspond respectively to 5 and 7 days under
high salt load. ** p<0.01 LH versus BN; † p<0.05 LH-13BN versus LH.
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Table 1
Renal function and plasma renin activity in LH, LH-13BN, BN-13LH and BN rats.
BN
n=10
LH
n=10
LH-13BN
n=10
BN-13LH
n=9
GFR (mL/min/100g)
 19 W 0.46±0.03 0.45±0.01 0.49±0.01 †† 0.49±0.02
 23 W 0.44±0.03 0.46±0.01 0.47±0.01 0.55±0.01 ‡‡
 25 W 0.44±0.02 0.46±0.01 0.45±0.02 0.49±0.02
U Prot (mg/24h/100g)
 19 W 4.98±0.29 30.59±2.64 ** 15.21±1.44 †† 5.71 ±0.81
 23 W 5.29±0.23 57.68±4.34 ** 21.88±2.50 †† 5.40±0.30
 25 W 5.27±0.21 55.26±3.51 ** 22.47±2.38 †† 5.20±0.73
U Na (mmol/L/100g)
 19 W 0.49±0.04 0.49±0.04 0.42±0.02 0.65±0.02 ‡‡
 23 W 1.32±0.09 2.76±0.24 ** 2.00±0.08 †† 1.95±0.09 ‡‡
 25 W 0.44±0.03 0.45±0.02 0.43±0.02 0.61 ±0.03 ‡‡
Na/K Urinary
 19 W 0.21 ±0.02 0.12±0.01 ** 0.11±0.01 0.21 ±0.01
 23 W 0.56±0.02 0.52±0.03 0.52±0.02 0.64±0.02 ‡‡
 25 W 0.20±0.01 0.10±0.01 ** 0.12±0.01 0.21 ±0.01
PRA (ng/mL/h)
 25 W 24.60±2.51 11.62±2.24 ** 12.19±1.15 24.33±2.53
Renal function in LH (n=10), LH-13BN (n=10), BN-13LH (n=9) and BN rats (n=10) at the age of 19 weeks (baseline diet condition), 23 weeks (1
% NaCl as drinking water) and 25 weeks (baseline diet condition).
GFR, Glomerular Filtration Rate (estimated by creatinine clearance); U Prot, Proteinuria; U Na, Relative excretion of sodium; PRA, Plama Renin
Activity
**
p < 0.01 LH versus BN
††
p < 0.01 LH-13BN versus LH
‡‡
p < 0.01 BN-13LH versus BN
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Table 2
Plasma characteristics in fasted 25 week-old LH, LH-13BN, BN-13LH and BN rats.
BN
n=10
LH
n=10
LH-13BN
n=10
BN-13LH
n=9
Cholesterol (mmol/L) 1.59±0.05 (9) 3.44±0.21 ** 2.07±0.07 †† 1.58±0.03
Triglycerides (mmol/L) 0.57±0.02 0.99±0.08 ** 0.71 ±0.05 †† 0.58±0.02
Glucose (mmol/L) 7.39±0.16 7.81 ±0.22 7.67±0.18 7.66±0.41
Insulin (mUI/L) 20.37±0.91 29.17±1.42 ** 30.84±1.62 23.41 ±1.88
Insulin/glucose 2.76±0.13 3.80±0.25 ** 4.02±0.23 3.06±0.17
Numbers in brackets indicate the number of rats if different.
**
p < 0.01 LH versus BN
††
p < 0.01 LH-13BN versus LH
‡
p < 0.05 BN-13LH versus BN
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